The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative Intent

Background: Patient-related factors, namely comorbidities, impact the clinical outcome of patients with diffuse large B-cell lymphoma (DLBCL). Methods: The prevalence and prognostic impact of comorbidities were examined using the validated scores Charlson Comorbidity Index (CCI) and Hematopoietic Ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocher, Florian, Mian, Michael, Seeber, Andreas, Fiegl, Michael, Stauder, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230391/
https://www.ncbi.nlm.nih.gov/pubmed/32252438
http://dx.doi.org/10.3390/jcm9041005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230391/
https://www.ncbi.nlm.nih.gov/pubmed/32252438
http://dx.doi.org/10.3390/jcm9041005

Ejemplares similares